VRCA · Verrica Pharmaceuticals Inc. · Investor Relations
$3.56
-0.16 (-4.30%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Nov 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current business plan and current capital resources, combined with the uncertainty regarding the availability of additional funding, we have concluded that there is substantial doubt regarding our ability to continue as a going concern within one year after the date these consolidated financial statements are issued.”View the 10-Q filed Nov 13, 2026
Market Cap
$61.16M
Shares
17.18M
Volume · Nov 13
18.68K
Avg daily vol (3M)
72.22K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-11-19 13:30 UTC | Jefferies Global Healthcare Conference in London | Conference |
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-11-12 | Verrica Pharmaceuticals Inc. Q3 FY2026 Earnings Call | Earnings call |
| 2026-10-15 | 2026 PeDRA Annual Conference | Conference |
| 2026-09-14 | September 14, 2026 | Event |
| 2026-08-19 | August 19, 2026 | Event |
| 2026-08-06 | Q2 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-06-04 | Thursday, June 4, 2026 (11:05 am ET) | Webcast |
| 2026-05-19 | Tuesday, May 19, 2026 (1:30pm ET) | Webcast |
| 2026-05-15 | Friday, May 15, 2026 at 4:30 pm – 6:00 pm – Poster Number: LB1190 – VP-315 Demonstrates Potential Abscopal Effect in Untreated Non-Target Basal Cell Carcinoma (BCC) Tumors | Event |
| 2026-05-15 | 2026 Society for Investigative Dermatology (SID) Annual Meeting | Event |
| 2026-05-13 | May 13, 2026 | Event |
| 2026-05-12 | Tuesday, May 12, 2026 (4:30 pm ET) | Event |
| 2026-05-12 | Q1 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-03-11 | Earnings conference call (announced in 8-K) | Earnings call |
Key facts
CIK
1660334
CUSIP
92511W207
13F (30d)
46 filings
25 filers
Visit website
Investor relations